| 1 | similarly | 5,480 |
| 2 | accordingly | 1,478 |
| 3 | surprisingly | 892 |
| 4 | altogether | 790 |
| 5 | unexpectedly | 569 |
| 6 | alternatively | 548 |
| 7 | firstly | 527 |
| 8 | nowadays | 524 |
| 9 | paradoxically | 258 |
| 10 | correspondingly | 241 |
| 11 | mechanistically | 184 |
| 12 | cumulatively | 92 |
| 13 | anyway | 37 |
| 14 | expectedly | 21 |
| 15 | analogously | 16 |
| 16 | encouragingly | 15 |
| 17 | complementarily | 13 |
| 18 | pcc6803 | 12 |
| 19 | reassuringly | 11 |
| 20 | unsurprisingly | 10 |
| 21 | brasiletto | 9 |
| 22 | anyhow | 8 |
| 23 | caroline | 8 |
| 24 | cedrol | 7 |
| 25 | congruently | 7 |
| 26 | hq-3 | 7 |
| 27 | inexplicably | 6 |
| 28 | now-a-days | 6 |
| 29 | 19-3-19 | 5 |
| 30 | aggr | 5 |
| 31 | escin | 5 |
| 32 | go.10213 | 5 |
| 33 | auxology | 4 |
| 34 | del/ins | 4 |
| 35 | frigidicarnis | 4 |
| 36 | h/ms | 4 |
| 37 | hemodilutional | 4 |
| 38 | pgl4002 | 4 |
| 39 | roc-analysis | 4 |
| 40 | vivus | 4 |
| 41 | 2,2-dimethyl-1,3-dioxolane | 3 |
| 42 | 4.1- | 3 |
| 43 | benzophenanthridines | 3 |
| 44 | buspiron | 3 |
| 45 | correlatively | 3 |
| 46 | crta | 3 |
| 47 | ding-chuan-tang | 3 |
| 48 | e263 | 3 |
| 49 | enduringly | 3 |
| 50 | energy-intensive | 3 |
| 51 | ginkgo* | 3 |
| 52 | immunoproteomics | 3 |
| 53 | indubitably | 3 |
| 54 | intermedin | 3 |
| 55 | mutmbutim | 3 |
| 56 | nxd30001 | 3 |
| 57 | opc-8490 | 3 |
| 58 | postinclusion | 3 |
| 59 | pra-levels | 3 |
| 60 | similarily | 3 |
| 61 | xiang-sha-liu-jun-zi-tang | 3 |
| 62 | -17.08 | 2 |
| 63 | -17.66 | 2 |
| 64 | 1881/2006 | 2 |
| 65 | acetylsalicylic-acid | 2 |
| 66 | actrn12611000606987 | 2 |
| 67 | afqlq1 | 2 |
| 68 | ah-2 | 2 |
| 69 | amoxicillin-clavulante | 2 |
| 70 | analogically | 2 |
| 71 | asian/others | 2 |
| 72 | bernal | 2 |
| 73 | bs3 | 2 |
| 74 | cd45-/133+/34+ | 2 |
| 75 | cochleotoxicity | 2 |
| 76 | correspondently | 2 |
| 77 | disconcertingly | 2 |
| 78 | ensemble-averaged | 2 |
| 79 | f33 | 2 |
| 80 | freedom-from-bpar | 2 |
| 81 | fsmm22 | 2 |
| 82 | haptoglobinemia | 2 |
| 83 | hepatic-intestinal | 2 |
| 84 | high-amount | 2 |
| 85 | ll-29 | 2 |
| 86 | luked | 2 |
| 87 | manatunga | 2 |
| 88 | mesh- | 2 |
| 89 | nct00061321 | 2 |
| 90 | nct00388050 | 2 |
| 91 | pn.-igg/iga-titers | 2 |
| 92 | pneumo-otoscopy | 2 |
| 93 | pneumrx | 2 |
| 94 | pre-eruptively | 2 |
| 95 | promisingly | 2 |
| 96 | psr1 | 2 |
| 97 | rhobtb1 | 2 |
| 98 | rmo-40 | 2 |
| 99 | runihol | 2 |
| 100 | stat3- | 2 |
| 101 | suprathel | 2 |
| 102 | tea+l-name | 2 |
| 103 | telmisartin | 2 |
| 104 | thermo-alkali-stability | 2 |
| 105 | varro | 2 |
| 106 | xylo-oligomers | 2 |
| 107 | zixuedan | 2 |
| 108 | α-crystallin-type | 2 |
| 109 | -0.30±0.60 | 1 |
| 110 | -0.44-2.51 | 1 |
| 111 | -0.8190 | 1 |
| 112 | -1.2/day | 1 |
| 113 | -20.2/-10.4 | 1 |
| 114 | -5.84-6.86 | 1 |
| 115 | -£1244 | 1 |
| 116 | .2/1000 | 1 |
| 117 | .education | 1 |
| 118 | 0.003248 | 1 |
| 119 | 0.05μm | 1 |
| 120 | 0.0768 | 1 |
| 121 | 0.15±0.10 | 1 |
| 122 | 0.20+/-0.10 | 1 |
| 123 | 0.2405 | 1 |
| 124 | 0.2415 | 1 |
| 125 | 0.27±0.25 | 1 |
| 126 | 0.2mpa | 1 |
| 127 | 0.30l | 1 |
| 128 | 0.355ns | 1 |
| 129 | 0.3ng/ml | 1 |
| 130 | 0.459omega | 1 |
| 131 | 0.47±0.05ml/min | 1 |
| 132 | 0.50mm | 1 |
| 133 | 0.50±0.16 | 1 |
| 134 | 0.553omega | 1 |
| 135 | 0.5668 | 1 |
| 136 | 0.667-1.274 | 1 |
| 137 | 0.69±0.49 | 1 |
| 138 | 0.6ms/0.2ms | 1 |
| 139 | 0.7509 | 1 |
| 140 | 0.76+/-0.26 | 1 |
| 141 | 0.838±0.048 | 1 |
| 142 | 0.845±0.045 | 1 |
| 143 | 0.856±0.046 | 1 |
| 144 | 0.85°c | 1 |
| 145 | 0.9/1000 | 1 |
| 146 | 0.9172 | 1 |
| 147 | 0.9280 | 1 |
| 148 | 0·00-5·27 | 1 |
| 149 | 1.05±0.24 | 1 |
| 150 | 1.1799 | 1 |
| 151 | 1.32+/-0.09 | 1 |
| 152 | 1.3392 | 1 |
| 153 | 1.65±4.48 | 1 |
| 154 | 1.76±1.79 | 1 |
| 155 | 1.79+/-0.23 | 1 |
| 156 | 1.79/1.34 | 1 |
| 157 | 1.9h | 1 |
| 158 | 1.9±1.4 | 1 |
| 159 | 10,370/μl | 1 |
| 160 | 10.5years | 1 |
| 161 | 1021.63 | 1 |
| 162 | 103:20 | 1 |
| 163 | 106+/-2 | 1 |
| 164 | 106/µl | 1 |
| 165 | 106micromol/l | 1 |
| 166 | 107.4° | 1 |
| 167 | 10ng/l | 1 |
| 168 | 11.05+/-1.37 | 1 |
| 169 | 1156.3 | 1 |
| 170 | 1181/microl | 1 |
| 171 | 12.36±4.30 | 1 |
| 172 | 128.1/79.9 | 1 |
| 173 | 13/hr | 1 |
| 174 | 1345.13 | 1 |
| 175 | 137/75 | 1 |
| 176 | 13±12 | 1 |
| 177 | 14.4±2.6 | 1 |
| 178 | 145.4±112.0ml | 1 |
| 179 | 148+/-1.7 | 1 |
| 180 | 15,282 | 1 |
| 181 | 15,709 | 1 |
| 182 | 15.2/1000 | 1 |
| 183 | 152.94±85.59 | 1 |
| 184 | 156- | 1 |
| 185 | 157.84°c | 1 |
| 186 | 15:3 | 1 |
| 187 | 17,114 | 1 |
| 188 | 17.7/month | 1 |
| 189 | 171:1 | 1 |
| 190 | 18,802 | 1 |
| 191 | 18.2+/-2.4 | 1 |
| 192 | 1824g | 1 |
| 193 | 19,000/mm3 | 1 |
| 194 | 1944-2006 | 1 |
| 195 | 1:2,400 | 1 |
| 196 | 1:4,098 | 1 |
| 197 | 1:7.5 | 1 |
| 198 | 1·9:1 | 1 |
| 199 | 2,657,365 | 1 |
| 200 | 2.1+/-0.05 | 1 |
| 201 | 2.35μg/ml | 1 |
| 202 | 2.81‰ | 1 |
| 203 | 2.84-fold | 1 |
| 204 | 2.89/child-year | 1 |
| 205 | 21/1483 | 1 |
| 206 | 22.2+/-12.8 | 1 |
| 207 | 22.5-32.5°c | 1 |
| 208 | 220-278 | 1 |
| 209 | 2251bp | 1 |
| 210 | 227,235 | 1 |
| 211 | 23.1s | 1 |
| 212 | 23.3cc | 1 |
| 213 | 23·26 | 1 |
| 214 | 25.6ml/s | 1 |
| 215 | 25.75+/-3.92 | 1 |
| 216 | 25/8 | 1 |
| 217 | 27/12 | 1 |
| 218 | 29.94/16.32 | 1 |
| 219 | 290.4 | 1 |
| 220 | 3,2'-dhf-treated | 1 |
| 221 | 3,326.76 | 1 |
| 222 | 3.09±0.99 | 1 |
| 223 | 3.36∓2.31 | 1 |
| 224 | 3.3:6.7 | 1 |
| 225 | 3.4±2.7h | 1 |
| 226 | 3.67- | 1 |
| 227 | 3.69+/-1.09 | 1 |
| 228 | 30.25+/-9.16 | 1 |
| 229 | 30.6+/-1.6 | 1 |
| 230 | 31.1+/-2.15 | 1 |
| 231 | 31.22+15.44 | 1 |
| 232 | 3143rmb | 1 |
| 233 | 31683 | 1 |
| 234 | 32.23±12.71 | 1 |
| 235 | 32.5±4 | 1 |
| 236 | 34+/-21 | 1 |
| 237 | 34.85°c | 1 |
| 238 | 35.3+/-12.6 | 1 |
| 239 | 35.8±7.2 | 1 |
| 240 | 35/1,000 | 1 |
| 241 | 350μg/l | 1 |
| 242 | 36,293 | 1 |
| 243 | 36.1±6 | 1 |
| 244 | 36.4+/-5.4 | 1 |
| 245 | 36.5±0.67 | 1 |
| 246 | 38.7±0.01°c | 1 |
| 247 | 38.8±0.02°c | 1 |
| 248 | 4.1+/-2.3 | 1 |
| 249 | 4.24- | 1 |
| 250 | 4.37±1.38 | 1 |
| 251 | 4.425 | 1 |
| 252 | 4.8000 | 1 |
| 253 | 41.4±20.4 | 1 |
| 254 | 424.788mg/kg | 1 |
| 255 | 44.4/1000 | 1 |
| 256 | 47.6±0.2°c | 1 |
| 257 | 47:39 | 1 |
| 258 | 485.87 | 1 |
| 259 | 49.95±14.569 | 1 |
| 260 | 4:8 | 1 |
| 261 | 5,733,602 | 1 |
| 262 | 5.7-8.0 | 1 |
| 263 | 5.9±1.6 | 1 |
| 264 | 515,710 | 1 |
| 265 | 53.50±29.07 | 1 |
| 266 | 56:28 | 1 |
| 267 | 57.7+/-15.4 | 1 |
| 268 | 5929 | 1 |
| 269 | 6,090,040 | 1 |
| 270 | 6,609 | 1 |
| 271 | 6.0±2.3 | 1 |
| 272 | 6.2+/-0.4 | 1 |
| 273 | 6.2±0.53 | 1 |
| 274 | 6.58+/-4.26 | 1 |
| 275 | 6.5±3.0 | 1 |
| 276 | 6.75+/-0.64 | 1 |
| 277 | 6.76±2.71 | 1 |
| 278 | 6.8:1 | 1 |
| 279 | 60.6+/-15.9 | 1 |
| 280 | 60230.71 | 1 |
| 281 | 62.4±19.1 | 1 |
| 282 | 62yr | 1 |
| 283 | 63.1±8.9 | 1 |
| 284 | 66.75+/-3.44 | 1 |
| 285 | 66±111pg/ml | 1 |
| 286 | 68+/-3.3 | 1 |
| 287 | 7.15±0.69 | 1 |
| 288 | 7.52±2.41 | 1 |
| 289 | 7.6/day | 1 |
| 290 | 7.7+/-2.4 | 1 |
| 291 | 7.76±0.40 | 1 |
| 292 | 706±337 | 1 |
| 293 | 75.3cc | 1 |
| 294 | 75/140 | 1 |
| 295 | 76.29±17.93 | 1 |
| 296 | 76±20 | 1 |
| 297 | 779145 | 1 |
| 298 | 781/757 | 1 |
| 299 | 7961 | 1 |
| 300 | 8,195 | 1 |
| 301 | 8.3+/-11.6 | 1 |
| 302 | 80.19 | 1 |
| 303 | 80/30 | 1 |
| 304 | 816,884 | 1 |
| 305 | 82.2+/-7.2 | 1 |
| 306 | 849.1±100.3 | 1 |
| 307 | 9-14h | 1 |
| 308 | 9.38° | 1 |
| 309 | 9.4±2.2 | 1 |
| 310 | 9.5ml/s | 1 |
| 311 | 9.6º | 1 |
| 312 | 9.800 | 1 |
| 313 | 93.7±1.9 | 1 |
| 314 | 94.8+/-4.16 | 1 |
| 315 | 95.3+/-2.67 | 1 |
| 316 | 95.6±47.4 | 1 |
| 317 | 95.77±47.42 | 1 |
| 318 | 96.7+/-3.44 | 1 |
| 319 | 96.9+/-1.71 | 1 |
| 320 | 97.9±20.6cm/s | 1 |
| 321 | 98.5±0.01 | 1 |
| 322 | 98.9+/-2.99 | 1 |
| 323 | 99.7+/-0.52 | 1 |
| 324 | 997/100,000 | 1 |
| 325 | ad7a | 1 |
| 326 | aflagellary | 1 |
| 327 | always-present | 1 |
| 328 | anti-conservativeness | 1 |
| 329 | antisocially | 1 |
| 330 | astoundingly | 1 |
| 331 | barbera | 1 |
| 332 | biexponentially | 1 |
| 333 | bizzozero | 1 |
| 334 | c1201g | 1 |
| 335 | c3522t | 1 |
| 336 | cbt-cwit-dsbt | 1 |
| 337 | cca-cc | 1 |
| 338 | ch3cn/h2o | 1 |
| 339 | characterizated | 1 |
| 340 | cis-δ5 | 1 |
| 341 | clz/f | 1 |
| 342 | coffeine | 1 |
| 343 | cpt-stress | 1 |
| 344 | cross-pollinated | 1 |
| 345 | csca-1 | 1 |
| 346 | cytoplasm-localized | 1 |
| 347 | d=-0.02 | 1 |
| 348 | dalcetrapib+ezetimibe | 1 |
| 349 | de-flasked | 1 |
| 350 | defluorinated | 1 |
| 351 | diagnosed.however | 1 |
| 352 | dss-treatment | 1 |
| 353 | dz13/dotap/dope | 1 |
| 354 | earthed | 1 |
| 355 | education-led | 1 |
| 356 | eg2/eg1 | 1 |
| 357 | electrocuted | 1 |
| 358 | emphysema/copd | 1 |
| 359 | epa-lpc | 1 |
| 360 | erithema | 1 |
| 361 | ewlcx | 1 |
| 362 | fang-feng-tong-sheng-san | 1 |
| 363 | ff8241 | 1 |
| 364 | gram-stain-variable | 1 |
| 365 | hysicochemical | 1 |
| 366 | ignorantly | 1 |
| 367 | ikkε-knockdown | 1 |
| 368 | il-12p40/p70 | 1 |
| 369 | immunosuppression.furthermore | 1 |
| 370 | instrument-completion | 1 |
| 371 | isrctn41352631 | 1 |
| 372 | k-max | 1 |
| 373 | l-ficolin | 1 |
| 374 | less-than-dose-proportional | 1 |
| 375 | like-hypoglycemia | 1 |
| 376 | lipogensis | 1 |
| 377 | low-range | 1 |
| 378 | magratoxin | 1 |
| 379 | mariginal | 1 |
| 380 | maxclarity™ | 1 |
| 381 | mb-treatment | 1 |
| 382 | mct/lcts | 1 |
| 383 | meddiet+wl | 1 |
| 384 | mediators/substances | 1 |
| 385 | monophasically | 1 |
| 386 | msbr | 1 |
| 387 | mtorc1ser2448 | 1 |
| 388 | mu-power | 1 |
| 389 | mvo2/g | 1 |
| 390 | ni’s | 1 |
| 391 | njt-treatment | 1 |
| 392 | nonindicative | 1 |
| 393 | norbinaltorphimine | 1 |
| 394 | npy-saporin | 1 |
| 395 | occipitalia | 1 |
| 396 | off-loaded | 1 |
| 397 | ofhemocyte | 1 |
| 398 | ofpaclitaxel | 1 |
| 399 | or:0.918 | 1 |
| 400 | ors278 | 1 |
| 401 | overpaid | 1 |
| 402 | p-enos/enos | 1 |
| 403 | paco2significantly | 1 |
| 404 | parapubic | 1 |
| 405 | phosphorylated-smad2 | 1 |
| 406 | plats1 | 1 |
| 407 | post-booking | 1 |
| 408 | pound1112.64 | 1 |
| 409 | pound70,263 | 1 |
| 410 | pp38 | 1 |
| 411 | ppten | 1 |
| 412 | predrilled | 1 |
| 413 | produced.medline | 1 |
| 414 | proprioceptively | 1 |
| 415 | protein-ubiquitination | 1 |
| 416 | ps+=0.805 | 1 |
| 417 | puce | 1 |
| 418 | radiationsensibility | 1 |
| 419 | random-random | 1 |
| 420 | rbmktt-3 | 1 |
| 421 | recorded.thereafter | 1 |
| 422 | relativly | 1 |
| 423 | rhtl1a | 1 |
| 424 | rictor-mtor-dependent | 1 |
| 425 | ripening-dependent | 1 |
| 426 | rosglitazone | 1 |
| 427 | rygbp-induced | 1 |
| 428 | sddif | 1 |
| 429 | srcirc | 1 |
| 430 | st-5583 | 1 |
| 431 | st22 | 1 |
| 432 | stas-state | 1 |
| 433 | stumbles | 1 |
| 434 | substantial.overall | 1 |
| 435 | sun049t | 1 |
| 436 | tamoxifen.data | 1 |
| 437 | tenodera | 1 |
| 438 | thermoidea | 1 |
| 439 | thermopreferendum | 1 |
| 440 | timeconsuming | 1 |
| 441 | tnpa-blandm-3-blembl-trpf-dsbc-tnpa-suli-qacedeltai-aada2-dfra1 | 1 |
| 442 | totpar-3 | 1 |
| 443 | transmethylated | 1 |
| 444 | trifluoroethyl | 1 |
| 445 | trigleceride | 1 |
| 446 | trimorphic | 1 |
| 447 | trp86 | 1 |
| 448 | usd122 | 1 |
| 449 | usd138 | 1 |
| 450 | valinomycin | 1 |
| 451 | vldl-pon1 | 1 |
| 452 | waysides | 1 |
| 453 | whiled | 1 |
| 454 | within-ss | 1 |
| 455 | ~2.13-fold | 1 |
| 456 | £12,866 | 1 |
| 457 | £13,552/qaly | 1 |
| 458 | £1552 | 1 |
| 459 | £16,170 | 1 |
| 460 | £17,173 | 1 |
| 461 | £2039 | 1 |
| 462 | £3896 | 1 |
| 463 | £4126 | 1 |
| 464 | £7720 | 1 |
| 465 | £89,182 | 1 |
| 466 | γ-ntp/tp | 1 |
| 467 | δt° | 1 |
| 468 | €16,229 | 1 |
| 469 | €2,293 | 1 |
| 470 | €2747 | 1 |
| 471 | €39,783 | 1 |
| 472 | €4045 | 1 |
| 473 | €6455 | 1 |
| 474 | ∼1/1000 | 1 |
| 1 | -0.30±0.60 | 1 |
| 2 | -0.44-2.51 | 1 |
| 3 | -0.8190 | 1 |
| 4 | -1.2/day | 1 |
| 5 | -17.08 | 2 |
| 6 | -17.66 | 2 |
| 7 | -20.2/-10.4 | 1 |
| 8 | -5.84-6.86 | 1 |
| 9 | -£1244 | 1 |
| 10 | .2/1000 | 1 |
| 11 | .education | 1 |
| 12 | 0.003248 | 1 |
| 13 | 0.05μm | 1 |
| 14 | 0.0768 | 1 |
| 15 | 0.15±0.10 | 1 |
| 16 | 0.20+/-0.10 | 1 |
| 17 | 0.2405 | 1 |
| 18 | 0.2415 | 1 |
| 19 | 0.27±0.25 | 1 |
| 20 | 0.2mpa | 1 |
| 21 | 0.30l | 1 |
| 22 | 0.355ns | 1 |
| 23 | 0.3ng/ml | 1 |
| 24 | 0.459omega | 1 |
| 25 | 0.47±0.05ml/min | 1 |
| 26 | 0.50mm | 1 |
| 27 | 0.50±0.16 | 1 |
| 28 | 0.553omega | 1 |
| 29 | 0.5668 | 1 |
| 30 | 0.667-1.274 | 1 |
| 31 | 0.69±0.49 | 1 |
| 32 | 0.6ms/0.2ms | 1 |
| 33 | 0.7509 | 1 |
| 34 | 0.76+/-0.26 | 1 |
| 35 | 0.838±0.048 | 1 |
| 36 | 0.845±0.045 | 1 |
| 37 | 0.856±0.046 | 1 |
| 38 | 0.85°c | 1 |
| 39 | 0.9/1000 | 1 |
| 40 | 0.9172 | 1 |
| 41 | 0.9280 | 1 |
| 42 | 0·00-5·27 | 1 |
| 43 | 1.05±0.24 | 1 |
| 44 | 1.1799 | 1 |
| 45 | 1.32+/-0.09 | 1 |
| 46 | 1.3392 | 1 |
| 47 | 1.65±4.48 | 1 |
| 48 | 1.76±1.79 | 1 |
| 49 | 1.79+/-0.23 | 1 |
| 50 | 1.79/1.34 | 1 |
| 51 | 1.9h | 1 |
| 52 | 1.9±1.4 | 1 |
| 53 | 10,370/μl | 1 |
| 54 | 10.5years | 1 |
| 55 | 1021.63 | 1 |
| 56 | 103:20 | 1 |
| 57 | 106+/-2 | 1 |
| 58 | 106/µl | 1 |
| 59 | 106micromol/l | 1 |
| 60 | 107.4° | 1 |
| 61 | 10ng/l | 1 |
| 62 | 11.05+/-1.37 | 1 |
| 63 | 1156.3 | 1 |
| 64 | 1181/microl | 1 |
| 65 | 12.36±4.30 | 1 |
| 66 | 128.1/79.9 | 1 |
| 67 | 13/hr | 1 |
| 68 | 1345.13 | 1 |
| 69 | 137/75 | 1 |
| 70 | 13±12 | 1 |
| 71 | 14.4±2.6 | 1 |
| 72 | 145.4±112.0ml | 1 |
| 73 | 148+/-1.7 | 1 |
| 74 | 15,282 | 1 |
| 75 | 15,709 | 1 |
| 76 | 15.2/1000 | 1 |
| 77 | 152.94±85.59 | 1 |
| 78 | 156- | 1 |
| 79 | 157.84°c | 1 |
| 80 | 15:3 | 1 |
| 81 | 17,114 | 1 |
| 82 | 17.7/month | 1 |
| 83 | 171:1 | 1 |
| 84 | 18,802 | 1 |
| 85 | 18.2+/-2.4 | 1 |
| 86 | 1824g | 1 |
| 87 | 1881/2006 | 2 |
| 88 | 19,000/mm3 | 1 |
| 89 | 19-3-19 | 5 |
| 90 | 1944-2006 | 1 |
| 91 | 1:2,400 | 1 |
| 92 | 1:4,098 | 1 |
| 93 | 1:7.5 | 1 |
| 94 | 1·9:1 | 1 |
| 95 | 2,2-dimethyl-1,3-dioxolane | 3 |
| 96 | 2,657,365 | 1 |
| 97 | 2.1+/-0.05 | 1 |
| 98 | 2.35μg/ml | 1 |
| 99 | 2.81‰ | 1 |
| 100 | 2.84-fold | 1 |
| 101 | 2.89/child-year | 1 |
| 102 | 21/1483 | 1 |
| 103 | 22.2+/-12.8 | 1 |
| 104 | 22.5-32.5°c | 1 |
| 105 | 220-278 | 1 |
| 106 | 2251bp | 1 |
| 107 | 227,235 | 1 |
| 108 | 23.1s | 1 |
| 109 | 23.3cc | 1 |
| 110 | 23·26 | 1 |
| 111 | 25.6ml/s | 1 |
| 112 | 25.75+/-3.92 | 1 |
| 113 | 25/8 | 1 |
| 114 | 27/12 | 1 |
| 115 | 29.94/16.32 | 1 |
| 116 | 290.4 | 1 |
| 117 | 3,2'-dhf-treated | 1 |
| 118 | 3,326.76 | 1 |
| 119 | 3.09±0.99 | 1 |
| 120 | 3.36∓2.31 | 1 |
| 121 | 3.3:6.7 | 1 |
| 122 | 3.4±2.7h | 1 |
| 123 | 3.67- | 1 |
| 124 | 3.69+/-1.09 | 1 |
| 125 | 30.25+/-9.16 | 1 |
| 126 | 30.6+/-1.6 | 1 |
| 127 | 31.1+/-2.15 | 1 |
| 128 | 31.22+15.44 | 1 |
| 129 | 3143rmb | 1 |
| 130 | 31683 | 1 |
| 131 | 32.23±12.71 | 1 |
| 132 | 32.5±4 | 1 |
| 133 | 34+/-21 | 1 |
| 134 | 34.85°c | 1 |
| 135 | 35.3+/-12.6 | 1 |
| 136 | 35.8±7.2 | 1 |
| 137 | 35/1,000 | 1 |
| 138 | 350μg/l | 1 |
| 139 | 36,293 | 1 |
| 140 | 36.1±6 | 1 |
| 141 | 36.4+/-5.4 | 1 |
| 142 | 36.5±0.67 | 1 |
| 143 | 38.7±0.01°c | 1 |
| 144 | 38.8±0.02°c | 1 |
| 145 | 4.1+/-2.3 | 1 |
| 146 | 4.1- | 3 |
| 147 | 4.24- | 1 |
| 148 | 4.37±1.38 | 1 |
| 149 | 4.425 | 1 |
| 150 | 4.8000 | 1 |
| 151 | 41.4±20.4 | 1 |
| 152 | 424.788mg/kg | 1 |
| 153 | 44.4/1000 | 1 |
| 154 | 47.6±0.2°c | 1 |
| 155 | 47:39 | 1 |
| 156 | 485.87 | 1 |
| 157 | 49.95±14.569 | 1 |
| 158 | 4:8 | 1 |
| 159 | 5,733,602 | 1 |
| 160 | 5.7-8.0 | 1 |
| 161 | 5.9±1.6 | 1 |
| 162 | 515,710 | 1 |
| 163 | 53.50±29.07 | 1 |
| 164 | 56:28 | 1 |
| 165 | 57.7+/-15.4 | 1 |
| 166 | 5929 | 1 |
| 167 | 6,090,040 | 1 |
| 168 | 6,609 | 1 |
| 169 | 6.0±2.3 | 1 |
| 170 | 6.2+/-0.4 | 1 |
| 171 | 6.2±0.53 | 1 |
| 172 | 6.58+/-4.26 | 1 |
| 173 | 6.5±3.0 | 1 |
| 174 | 6.75+/-0.64 | 1 |
| 175 | 6.76±2.71 | 1 |
| 176 | 6.8:1 | 1 |
| 177 | 60.6+/-15.9 | 1 |
| 178 | 60230.71 | 1 |
| 179 | 62.4±19.1 | 1 |
| 180 | 62yr | 1 |
| 181 | 63.1±8.9 | 1 |
| 182 | 66.75+/-3.44 | 1 |
| 183 | 66±111pg/ml | 1 |
| 184 | 68+/-3.3 | 1 |
| 185 | 7.15±0.69 | 1 |
| 186 | 7.52±2.41 | 1 |
| 187 | 7.6/day | 1 |
| 188 | 7.7+/-2.4 | 1 |
| 189 | 7.76±0.40 | 1 |
| 190 | 706±337 | 1 |
| 191 | 75.3cc | 1 |
| 192 | 75/140 | 1 |
| 193 | 76.29±17.93 | 1 |
| 194 | 76±20 | 1 |
| 195 | 779145 | 1 |
| 196 | 781/757 | 1 |
| 197 | 7961 | 1 |
| 198 | 8,195 | 1 |
| 199 | 8.3+/-11.6 | 1 |
| 200 | 80.19 | 1 |
| 201 | 80/30 | 1 |
| 202 | 816,884 | 1 |
| 203 | 82.2+/-7.2 | 1 |
| 204 | 849.1±100.3 | 1 |
| 205 | 9-14h | 1 |
| 206 | 9.38° | 1 |
| 207 | 9.4±2.2 | 1 |
| 208 | 9.5ml/s | 1 |
| 209 | 9.6º | 1 |
| 210 | 9.800 | 1 |
| 211 | 93.7±1.9 | 1 |
| 212 | 94.8+/-4.16 | 1 |
| 213 | 95.3+/-2.67 | 1 |
| 214 | 95.6±47.4 | 1 |
| 215 | 95.77±47.42 | 1 |
| 216 | 96.7+/-3.44 | 1 |
| 217 | 96.9+/-1.71 | 1 |
| 218 | 97.9±20.6cm/s | 1 |
| 219 | 98.5±0.01 | 1 |
| 220 | 98.9+/-2.99 | 1 |
| 221 | 99.7+/-0.52 | 1 |
| 222 | 997/100,000 | 1 |
| 223 | accordingly | 1,478 |
| 224 | acetylsalicylic-acid | 2 |
| 225 | actrn12611000606987 | 2 |
| 226 | ad7a | 1 |
| 227 | aflagellary | 1 |
| 228 | afqlq1 | 2 |
| 229 | aggr | 5 |
| 230 | ah-2 | 2 |
| 231 | alternatively | 548 |
| 232 | altogether | 790 |
| 233 | always-present | 1 |
| 234 | amoxicillin-clavulante | 2 |
| 235 | analogically | 2 |
| 236 | analogously | 16 |
| 237 | anti-conservativeness | 1 |
| 238 | antisocially | 1 |
| 239 | anyhow | 8 |
| 240 | anyway | 37 |
| 241 | asian/others | 2 |
| 242 | astoundingly | 1 |
| 243 | auxology | 4 |
| 244 | barbera | 1 |
| 245 | benzophenanthridines | 3 |
| 246 | bernal | 2 |
| 247 | biexponentially | 1 |
| 248 | bizzozero | 1 |
| 249 | brasiletto | 9 |
| 250 | bs3 | 2 |
| 251 | buspiron | 3 |
| 252 | c1201g | 1 |
| 253 | c3522t | 1 |
| 254 | caroline | 8 |
| 255 | cbt-cwit-dsbt | 1 |
| 256 | cca-cc | 1 |
| 257 | cd45-/133+/34+ | 2 |
| 258 | cedrol | 7 |
| 259 | ch3cn/h2o | 1 |
| 260 | characterizated | 1 |
| 261 | cis-δ5 | 1 |
| 262 | clz/f | 1 |
| 263 | cochleotoxicity | 2 |
| 264 | coffeine | 1 |
| 265 | complementarily | 13 |
| 266 | congruently | 7 |
| 267 | correlatively | 3 |
| 268 | correspondently | 2 |
| 269 | correspondingly | 241 |
| 270 | cpt-stress | 1 |
| 271 | cross-pollinated | 1 |
| 272 | crta | 3 |
| 273 | csca-1 | 1 |
| 274 | cumulatively | 92 |
| 275 | cytoplasm-localized | 1 |
| 276 | d=-0.02 | 1 |
| 277 | dalcetrapib+ezetimibe | 1 |
| 278 | de-flasked | 1 |
| 279 | defluorinated | 1 |
| 280 | del/ins | 4 |
| 281 | diagnosed.however | 1 |
| 282 | ding-chuan-tang | 3 |
| 283 | disconcertingly | 2 |
| 284 | dss-treatment | 1 |
| 285 | dz13/dotap/dope | 1 |
| 286 | e263 | 3 |
| 287 | earthed | 1 |
| 288 | education-led | 1 |
| 289 | eg2/eg1 | 1 |
| 290 | electrocuted | 1 |
| 291 | emphysema/copd | 1 |
| 292 | encouragingly | 15 |
| 293 | enduringly | 3 |
| 294 | energy-intensive | 3 |
| 295 | ensemble-averaged | 2 |
| 296 | epa-lpc | 1 |
| 297 | erithema | 1 |
| 298 | escin | 5 |
| 299 | ewlcx | 1 |
| 300 | expectedly | 21 |
| 301 | f33 | 2 |
| 302 | fang-feng-tong-sheng-san | 1 |
| 303 | ff8241 | 1 |
| 304 | firstly | 527 |
| 305 | freedom-from-bpar | 2 |
| 306 | frigidicarnis | 4 |
| 307 | fsmm22 | 2 |
| 308 | ginkgo* | 3 |
| 309 | go.10213 | 5 |
| 310 | gram-stain-variable | 1 |
| 311 | h/ms | 4 |
| 312 | haptoglobinemia | 2 |
| 313 | hemodilutional | 4 |
| 314 | hepatic-intestinal | 2 |
| 315 | high-amount | 2 |
| 316 | hq-3 | 7 |
| 317 | hysicochemical | 1 |
| 318 | ignorantly | 1 |
| 319 | ikkε-knockdown | 1 |
| 320 | il-12p40/p70 | 1 |
| 321 | immunoproteomics | 3 |
| 322 | immunosuppression.furthermore | 1 |
| 323 | indubitably | 3 |
| 324 | inexplicably | 6 |
| 325 | instrument-completion | 1 |
| 326 | intermedin | 3 |
| 327 | isrctn41352631 | 1 |
| 328 | k-max | 1 |
| 329 | l-ficolin | 1 |
| 330 | less-than-dose-proportional | 1 |
| 331 | like-hypoglycemia | 1 |
| 332 | lipogensis | 1 |
| 333 | ll-29 | 2 |
| 334 | low-range | 1 |
| 335 | luked | 2 |
| 336 | magratoxin | 1 |
| 337 | manatunga | 2 |
| 338 | mariginal | 1 |
| 339 | maxclarity™ | 1 |
| 340 | mb-treatment | 1 |
| 341 | mct/lcts | 1 |
| 342 | mechanistically | 184 |
| 343 | meddiet+wl | 1 |
| 344 | mediators/substances | 1 |
| 345 | mesh- | 2 |
| 346 | monophasically | 1 |
| 347 | msbr | 1 |
| 348 | mtorc1ser2448 | 1 |
| 349 | mu-power | 1 |
| 350 | mutmbutim | 3 |
| 351 | mvo2/g | 1 |
| 352 | nct00061321 | 2 |
| 353 | nct00388050 | 2 |
| 354 | ni’s | 1 |
| 355 | njt-treatment | 1 |
| 356 | nonindicative | 1 |
| 357 | norbinaltorphimine | 1 |
| 358 | now-a-days | 6 |
| 359 | nowadays | 524 |
| 360 | npy-saporin | 1 |
| 361 | nxd30001 | 3 |
| 362 | occipitalia | 1 |
| 363 | off-loaded | 1 |
| 364 | ofhemocyte | 1 |
| 365 | ofpaclitaxel | 1 |
| 366 | opc-8490 | 3 |
| 367 | or:0.918 | 1 |
| 368 | ors278 | 1 |
| 369 | overpaid | 1 |
| 370 | p-enos/enos | 1 |
| 371 | paco2significantly | 1 |
| 372 | paradoxically | 258 |
| 373 | parapubic | 1 |
| 374 | pcc6803 | 12 |
| 375 | pgl4002 | 4 |
| 376 | phosphorylated-smad2 | 1 |
| 377 | plats1 | 1 |
| 378 | pn.-igg/iga-titers | 2 |
| 379 | pneumo-otoscopy | 2 |
| 380 | pneumrx | 2 |
| 381 | post-booking | 1 |
| 382 | postinclusion | 3 |
| 383 | pound1112.64 | 1 |
| 384 | pound70,263 | 1 |
| 385 | pp38 | 1 |
| 386 | ppten | 1 |
| 387 | pra-levels | 3 |
| 388 | pre-eruptively | 2 |
| 389 | predrilled | 1 |
| 390 | produced.medline | 1 |
| 391 | promisingly | 2 |
| 392 | proprioceptively | 1 |
| 393 | protein-ubiquitination | 1 |
| 394 | ps+=0.805 | 1 |
| 395 | psr1 | 2 |
| 396 | puce | 1 |
| 397 | radiationsensibility | 1 |
| 398 | random-random | 1 |
| 399 | rbmktt-3 | 1 |
| 400 | reassuringly | 11 |
| 401 | recorded.thereafter | 1 |
| 402 | relativly | 1 |
| 403 | rhobtb1 | 2 |
| 404 | rhtl1a | 1 |
| 405 | rictor-mtor-dependent | 1 |
| 406 | ripening-dependent | 1 |
| 407 | rmo-40 | 2 |
| 408 | roc-analysis | 4 |
| 409 | rosglitazone | 1 |
| 410 | runihol | 2 |
| 411 | rygbp-induced | 1 |
| 412 | sddif | 1 |
| 413 | similarily | 3 |
| 414 | similarly | 5,480 |
| 415 | srcirc | 1 |
| 416 | st-5583 | 1 |
| 417 | st22 | 1 |
| 418 | stas-state | 1 |
| 419 | stat3- | 2 |
| 420 | stumbles | 1 |
| 421 | substantial.overall | 1 |
| 422 | sun049t | 1 |
| 423 | suprathel | 2 |
| 424 | surprisingly | 892 |
| 425 | tamoxifen.data | 1 |
| 426 | tea+l-name | 2 |
| 427 | telmisartin | 2 |
| 428 | tenodera | 1 |
| 429 | thermo-alkali-stability | 2 |
| 430 | thermoidea | 1 |
| 431 | thermopreferendum | 1 |
| 432 | timeconsuming | 1 |
| 433 | tnpa-blandm-3-blembl-trpf-dsbc-tnpa-suli-qacedeltai-aada2-dfra1 | 1 |
| 434 | totpar-3 | 1 |
| 435 | transmethylated | 1 |
| 436 | trifluoroethyl | 1 |
| 437 | trigleceride | 1 |
| 438 | trimorphic | 1 |
| 439 | trp86 | 1 |
| 440 | unexpectedly | 569 |
| 441 | unsurprisingly | 10 |
| 442 | usd122 | 1 |
| 443 | usd138 | 1 |
| 444 | valinomycin | 1 |
| 445 | varro | 2 |
| 446 | vivus | 4 |
| 447 | vldl-pon1 | 1 |
| 448 | waysides | 1 |
| 449 | whiled | 1 |
| 450 | within-ss | 1 |
| 451 | xiang-sha-liu-jun-zi-tang | 3 |
| 452 | xylo-oligomers | 2 |
| 453 | zixuedan | 2 |
| 454 | ~2.13-fold | 1 |
| 455 | £12,866 | 1 |
| 456 | £13,552/qaly | 1 |
| 457 | £1552 | 1 |
| 458 | £16,170 | 1 |
| 459 | £17,173 | 1 |
| 460 | £2039 | 1 |
| 461 | £3896 | 1 |
| 462 | £4126 | 1 |
| 463 | £7720 | 1 |
| 464 | £89,182 | 1 |
| 465 | α-crystallin-type | 2 |
| 466 | γ-ntp/tp | 1 |
| 467 | δt° | 1 |
| 468 | €16,229 | 1 |
| 469 | €2,293 | 1 |
| 470 | €2747 | 1 |
| 471 | €39,783 | 1 |
| 472 | €4045 | 1 |
| 473 | €6455 | 1 |
| 474 | ∼1/1000 | 1 |
| 1 | ginkgo* | 3 |
| 2 | cd45-/133+/34+ | 2 |
| 3 | 4.1- | 3 |
| 4 | stat3- | 2 |
| 5 | 4.24- | 1 |
| 6 | 156- | 1 |
| 7 | 3.67- | 1 |
| 8 | mesh- | 2 |
| 9 | 6.5±3.0 | 1 |
| 10 | 5.7-8.0 | 1 |
| 11 | 997/100,000 | 1 |
| 12 | 35/1,000 | 1 |
| 13 | ∼1/1000 | 1 |
| 14 | .2/1000 | 1 |
| 15 | 15.2/1000 | 1 |
| 16 | 44.4/1000 | 1 |
| 17 | 0.9/1000 | 1 |
| 18 | 4.8000 | 1 |
| 19 | 1:2,400 | 1 |
| 20 | 9.800 | 1 |
| 21 | 0.20+/-0.10 | 1 |
| 22 | 0.15±0.10 | 1 |
| 23 | 515,710 | 1 |
| 24 | £7720 | 1 |
| 25 | 103:20 | 1 |
| 26 | 76±20 | 1 |
| 27 | 12.36±4.30 | 1 |
| 28 | 80/30 | 1 |
| 29 | rmo-40 | 2 |
| 30 | 7.76±0.40 | 1 |
| 31 | 6,090,040 | 1 |
| 32 | 75/140 | 1 |
| 33 | nct00388050 | 2 |
| 34 | -0.30±0.60 | 1 |
| 35 | £16,170 | 1 |
| 36 | il-12p40/p70 | 1 |
| 37 | 0.9280 | 1 |
| 38 | -0.8190 | 1 |
| 39 | opc-8490 | 3 |
| 40 | csca-1 | 1 |
| 41 | 62.4±19.1 | 1 |
| 42 | 98.5±0.01 | 1 |
| 43 | nxd30001 | 3 |
| 44 | 34+/-21 | 1 |
| 45 | nct00061321 | 2 |
| 46 | 3.36∓2.31 | 1 |
| 47 | isrctn41352631 | 1 |
| 48 | 7.52±2.41 | 1 |
| 49 | ff8241 | 1 |
| 50 | -0.44-2.51 | 1 |
| 51 | 7961 | 1 |
| 52 | 60230.71 | 1 |
| 53 | 96.9+/-1.71 | 1 |
| 54 | 32.23±12.71 | 1 |
| 55 | 6.76±2.71 | 1 |
| 56 | 171:1 | 1 |
| 57 | 6.8:1 | 1 |
| 58 | 1·9:1 | 1 |
| 59 | tnpa-blandm-3-blembl-trpf-dsbc-tnpa-suli-qacedeltai-aada2-dfra1 | 1 |
| 60 | rhobtb1 | 2 |
| 61 | eg2/eg1 | 1 |
| 62 | vldl-pon1 | 1 |
| 63 | afqlq1 | 2 |
| 64 | psr1 | 2 |
| 65 | plats1 | 1 |
| 66 | 106+/-2 | 1 |
| 67 | ah-2 | 2 |
| 68 | 9.4±2.2 | 1 |
| 69 | 82.2+/-7.2 | 1 |
| 70 | 35.8±7.2 | 1 |
| 71 | d=-0.02 | 1 |
| 72 | pgl4002 | 4 |
| 73 | 5,733,602 | 1 |
| 74 | 18,802 | 1 |
| 75 | 27/12 | 1 |
| 76 | 13±12 | 1 |
| 77 | usd122 | 1 |
| 78 | fsmm22 | 2 |
| 79 | st22 | 1 |
| 80 | 29.94/16.32 | 1 |
| 81 | 95.77±47.42 | 1 |
| 82 | 99.7+/-0.52 | 1 |
| 83 | £1552 | 1 |
| 84 | 0.9172 | 1 |
| 85 | £89,182 | 1 |
| 86 | 15,282 | 1 |
| 87 | 25.75+/-3.92 | 1 |
| 88 | 1.3392 | 1 |
| 89 | phosphorylated-smad2 | 1 |
| 90 | hq-3 | 7 |
| 91 | totpar-3 | 1 |
| 92 | rbmktt-3 | 1 |
| 93 | 849.1±100.3 | 1 |
| 94 | 4.1+/-2.3 | 1 |
| 95 | 6.0±2.3 | 1 |
| 96 | 68+/-3.3 | 1 |
| 97 | 1156.3 | 1 |
| 98 | pcc6803 | 12 |
| 99 | 1345.13 | 1 |
| 100 | go.10213 | 5 |
| 101 | 1.79+/-0.23 | 1 |
| 102 | f33 | 2 |
| 103 | 6.2±0.53 | 1 |
| 104 | 1021.63 | 1 |
| 105 | pound70,263 | 1 |
| 106 | e263 | 3 |
| 107 | £17,173 | 1 |
| 108 | 21/1483 | 1 |
| 109 | st-5583 | 1 |
| 110 | 31683 | 1 |
| 111 | €39,783 | 1 |
| 112 | 76.29±17.93 | 1 |
| 113 | €2,293 | 1 |
| 114 | 36,293 | 1 |
| 115 | 15:3 | 1 |
| 116 | 19,000/mm3 | 1 |
| 117 | bs3 | 2 |
| 118 | 6.2+/-0.4 | 1 |
| 119 | -20.2/-10.4 | 1 |
| 120 | 41.4±20.4 | 1 |
| 121 | 290.4 | 1 |
| 122 | 1.9±1.4 | 1 |
| 123 | 18.2+/-2.4 | 1 |
| 124 | 7.7+/-2.4 | 1 |
| 125 | 36.4+/-5.4 | 1 |
| 126 | 57.7+/-15.4 | 1 |
| 127 | 95.6±47.4 | 1 |
| 128 | 17,114 | 1 |
| 129 | 1.05±0.24 | 1 |
| 130 | 1.79/1.34 | 1 |
| 131 | 66.75+/-3.44 | 1 |
| 132 | 96.7+/-3.44 | 1 |
| 133 | 31.22+15.44 | 1 |
| 134 | -£1244 | 1 |
| 135 | 6.75+/-0.64 | 1 |
| 136 | pound1112.64 | 1 |
| 137 | 0.667-1.274 | 1 |
| 138 | 816,884 | 1 |
| 139 | 32.5±4 | 1 |
| 140 | 1:7.5 | 1 |
| 141 | 2.1+/-0.05 | 1 |
| 142 | 0.2405 | 1 |
| 143 | ps+=0.805 | 1 |
| 144 | 31.1+/-2.15 | 1 |
| 145 | 0.2415 | 1 |
| 146 | 0.27±0.25 | 1 |
| 147 | 4.425 | 1 |
| 148 | 227,235 | 1 |
| 149 | 0.845±0.045 | 1 |
| 150 | €4045 | 1 |
| 151 | 779145 | 1 |
| 152 | €6455 | 1 |
| 153 | 2,657,365 | 1 |
| 154 | 137/75 | 1 |
| 155 | 8,195 | 1 |
| 156 | cis-δ5 | 1 |
| 157 | 30.6+/-1.6 | 1 |
| 158 | 8.3+/-11.6 | 1 |
| 159 | 5.9±1.6 | 1 |
| 160 | 35.3+/-12.6 | 1 |
| 161 | 14.4±2.6 | 1 |
| 162 | 1944-2006 | 1 |
| 163 | 1881/2006 | 2 |
| 164 | 0.50±0.16 | 1 |
| 165 | 94.8+/-4.16 | 1 |
| 166 | 30.25+/-9.16 | 1 |
| 167 | 0.76+/-0.26 | 1 |
| 168 | 6.58+/-4.26 | 1 |
| 169 | £4126 | 1 |
| 170 | 23·26 | 1 |
| 171 | 0.856±0.046 | 1 |
| 172 | -17.66 | 2 |
| 173 | £12,866 | 1 |
| 174 | 3,326.76 | 1 |
| 175 | -5.84-6.86 | 1 |
| 176 | trp86 | 1 |
| 177 | £3896 | 1 |
| 178 | 36.1±6 | 1 |
| 179 | 148+/-1.7 | 1 |
| 180 | 3.3:6.7 | 1 |
| 181 | 53.50±29.07 | 1 |
| 182 | 0·00-5·27 | 1 |
| 183 | 11.05+/-1.37 | 1 |
| 184 | 706±337 | 1 |
| 185 | €2747 | 1 |
| 186 | 781/757 | 1 |
| 187 | 36.5±0.67 | 1 |
| 188 | 95.3+/-2.67 | 1 |
| 189 | 485.87 | 1 |
| 190 | actrn12611000606987 | 2 |
| 191 | 22.2+/-12.8 | 1 |
| 192 | 25/8 | 1 |
| 193 | -17.08 | 2 |
| 194 | or:0.918 | 1 |
| 195 | 56:28 | 1 |
| 196 | 4.37±1.38 | 1 |
| 197 | usd138 | 1 |
| 198 | pp38 | 1 |
| 199 | 1.65±4.48 | 1 |
| 200 | 0.838±0.048 | 1 |
| 201 | 0.003248 | 1 |
| 202 | mtorc1ser2448 | 1 |
| 203 | 0.5668 | 1 |
| 204 | 0.0768 | 1 |
| 205 | 220-278 | 1 |
| 206 | ors278 | 1 |
| 207 | 1:4,098 | 1 |
| 208 | 4:8 | 1 |
| 209 | 93.7±1.9 | 1 |
| 210 | 60.6+/-15.9 | 1 |
| 211 | 63.1±8.9 | 1 |
| 212 | 128.1/79.9 | 1 |
| 213 | 1.32+/-0.09 | 1 |
| 214 | 3.69+/-1.09 | 1 |
| 215 | 0.7509 | 1 |
| 216 | 6,609 | 1 |
| 217 | 15,709 | 1 |
| 218 | 19-3-19 | 5 |
| 219 | 80.19 | 1 |
| 220 | ll-29 | 2 |
| 221 | €16,229 | 1 |
| 222 | 5929 | 1 |
| 223 | £2039 | 1 |
| 224 | 47:39 | 1 |
| 225 | 0.69±0.49 | 1 |
| 226 | 152.94±85.59 | 1 |
| 227 | 7.15±0.69 | 1 |
| 228 | 49.95±14.569 | 1 |
| 229 | 1.76±1.79 | 1 |
| 230 | 3.09±0.99 | 1 |
| 231 | 98.9+/-2.99 | 1 |
| 232 | 1.1799 | 1 |
| 233 | rhtl1a | 1 |
| 234 | ad7a | 1 |
| 235 | thermoidea | 1 |
| 236 | 0.553omega | 1 |
| 237 | 0.459omega | 1 |
| 238 | manatunga | 2 |
| 239 | occipitalia | 1 |
| 240 | like-hypoglycemia | 1 |
| 241 | haptoglobinemia | 2 |
| 242 | erithema | 1 |
| 243 | 0.2mpa | 1 |
| 244 | barbera | 1 |
| 245 | tenodera | 1 |
| 246 | tamoxifen.data | 1 |
| 247 | crta | 3 |
| 248 | 3143rmb | 1 |
| 249 | cca-cc | 1 |
| 250 | 23.3cc | 1 |
| 251 | 75.3cc | 1 |
| 252 | parapubic | 1 |
| 253 | trimorphic | 1 |
| 254 | epa-lpc | 1 |
| 255 | srcirc | 1 |
| 256 | 38.7±0.01°c | 1 |
| 257 | 47.6±0.2°c | 1 |
| 258 | 38.8±0.02°c | 1 |
| 259 | 157.84°c | 1 |
| 260 | 22.5-32.5°c | 1 |
| 261 | 0.85°c | 1 |
| 262 | 34.85°c | 1 |
| 263 | rygbp-induced | 1 |
| 264 | off-loaded | 1 |
| 265 | ensemble-averaged | 2 |
| 266 | earthed | 1 |
| 267 | de-flasked | 1 |
| 268 | luked | 2 |
| 269 | education-led | 1 |
| 270 | whiled | 1 |
| 271 | predrilled | 1 |
| 272 | 3,2'-dhf-treated | 1 |
| 273 | transmethylated | 1 |
| 274 | cross-pollinated | 1 |
| 275 | defluorinated | 1 |
| 276 | characterizated | 1 |
| 277 | electrocuted | 1 |
| 278 | cytoplasm-localized | 1 |
| 279 | overpaid | 1 |
| 280 | acetylsalicylic-acid | 2 |
| 281 | ~2.13-fold | 1 |
| 282 | 2.84-fold | 1 |
| 283 | emphysema/copd | 1 |
| 284 | dalcetrapib+ezetimibe | 1 |
| 285 | puce | 1 |
| 286 | trigleceride | 1 |
| 287 | low-range | 1 |
| 288 | gram-stain-variable | 1 |
| 289 | tea+l-name | 2 |
| 290 | 2,2-dimethyl-1,3-dioxolane | 3 |
| 291 | coffeine | 1 |
| 292 | produced.medline | 1 |
| 293 | caroline | 8 |
| 294 | norbinaltorphimine | 1 |
| 295 | rosglitazone | 1 |
| 296 | dz13/dotap/dope | 1 |
| 297 | α-crystallin-type | 2 |
| 298 | immunosuppression.furthermore | 1 |
| 299 | stas-state | 1 |
| 300 | amoxicillin-clavulante | 2 |
| 301 | ofhemocyte | 1 |
| 302 | energy-intensive | 3 |
| 303 | nonindicative | 1 |
| 304 | clz/f | 1 |
| 305 | sddif | 1 |
| 306 | mvo2/g | 1 |
| 307 | c1201g | 1 |
| 308 | 1824g | 1 |
| 309 | 424.788mg/kg | 1 |
| 310 | xiang-sha-liu-jun-zi-tang | 3 |
| 311 | ding-chuan-tang | 3 |
| 312 | post-booking | 1 |
| 313 | timeconsuming | 1 |
| 314 | 9-14h | 1 |
| 315 | 3.4±2.7h | 1 |
| 316 | 1.9h | 1 |
| 317 | 17.7/month | 1 |
| 318 | 10ng/l | 1 |
| 319 | 350μg/l | 1 |
| 320 | 106micromol/l | 1 |
| 321 | 0.30l | 1 |
| 322 | hysicochemical | 1 |
| 323 | mariginal | 1 |
| 324 | hepatic-intestinal | 2 |
| 325 | less-than-dose-proportional | 1 |
| 326 | hemodilutional | 4 |
| 327 | bernal | 2 |
| 328 | suprathel | 2 |
| 329 | ofpaclitaxel | 1 |
| 330 | substantial.overall | 1 |
| 331 | 0.3ng/ml | 1 |
| 332 | 66±111pg/ml | 1 |
| 333 | 2.35μg/ml | 1 |
| 334 | 145.4±112.0ml | 1 |
| 335 | runihol | 2 |
| 336 | 1181/microl | 1 |
| 337 | cedrol | 7 |
| 338 | meddiet+wl | 1 |
| 339 | trifluoroethyl | 1 |
| 340 | 106/µl | 1 |
| 341 | 10,370/μl | 1 |
| 342 | mutmbutim | 3 |
| 343 | 0.50mm | 1 |
| 344 | random-random | 1 |
| 345 | thermopreferendum | 1 |
| 346 | 0.05μm | 1 |
| 347 | zixuedan | 2 |
| 348 | fang-feng-tong-sheng-san | 1 |
| 349 | ppten | 1 |
| 350 | escin | 5 |
| 351 | valinomycin | 1 |
| 352 | intermedin | 3 |
| 353 | l-ficolin | 1 |
| 354 | 0.47±0.05ml/min | 1 |
| 355 | npy-saporin | 1 |
| 356 | telmisartin | 2 |
| 357 | magratoxin | 1 |
| 358 | postinclusion | 3 |
| 359 | .education | 1 |
| 360 | protein-ubiquitination | 1 |
| 361 | instrument-completion | 1 |
| 362 | buspiron | 3 |
| 363 | ikkε-knockdown | 1 |
| 364 | ch3cn/h2o | 1 |
| 365 | bizzozero | 1 |
| 366 | varro | 2 |
| 367 | brasiletto | 9 |
| 368 | 2251bp | 1 |
| 369 | γ-ntp/tp | 1 |
| 370 | 2.89/child-year | 1 |
| 371 | freedom-from-bpar | 2 |
| 372 | msbr | 1 |
| 373 | altogether | 790 |
| 374 | recorded.thereafter | 1 |
| 375 | diagnosed.however | 1 |
| 376 | mu-power | 1 |
| 377 | aggr | 5 |
| 378 | 13/hr | 1 |
| 379 | 62yr | 1 |
| 380 | 9.5ml/s | 1 |
| 381 | 25.6ml/s | 1 |
| 382 | 97.9±20.6cm/s | 1 |
| 383 | 23.1s | 1 |
| 384 | immunoproteomics | 3 |
| 385 | mediators/substances | 1 |
| 386 | waysides | 1 |
| 387 | stumbles | 1 |
| 388 | benzophenanthridines | 3 |
| 389 | frigidicarnis | 4 |
| 390 | lipogensis | 1 |
| 391 | roc-analysis | 4 |
| 392 | pra-levels | 3 |
| 393 | h/ms | 4 |
| 394 | 0.6ms/0.2ms | 1 |
| 395 | 0.355ns | 1 |
| 396 | del/ins | 4 |
| 397 | p-enos/enos | 1 |
| 398 | 10.5years | 1 |
| 399 | asian/others | 2 |
| 400 | xylo-oligomers | 2 |
| 401 | pn.-igg/iga-titers | 2 |
| 402 | within-ss | 1 |
| 403 | anti-conservativeness | 1 |
| 404 | cpt-stress | 1 |
| 405 | mct/lcts | 1 |
| 406 | vivus | 4 |
| 407 | now-a-days | 6 |
| 408 | nowadays | 524 |
| 409 | ni’s | 1 |
| 410 | c3522t | 1 |
| 411 | sun049t | 1 |
| 412 | cbt-cwit-dsbt | 1 |
| 413 | ripening-dependent | 1 |
| 414 | rictor-mtor-dependent | 1 |
| 415 | mb-treatment | 1 |
| 416 | dss-treatment | 1 |
| 417 | njt-treatment | 1 |
| 418 | always-present | 1 |
| 419 | high-amount | 2 |
| 420 | anyhow | 8 |
| 421 | k-max | 1 |
| 422 | ewlcx | 1 |
| 423 | pneumrx | 2 |
| 424 | -1.2/day | 1 |
| 425 | 7.6/day | 1 |
| 426 | anyway | 37 |
| 427 | auxology | 4 |
| 428 | £13,552/qaly | 1 |
| 429 | inexplicably | 6 |
| 430 | indubitably | 3 |
| 431 | expectedly | 21 |
| 432 | unexpectedly | 569 |
| 433 | correlatively | 3 |
| 434 | cumulatively | 92 |
| 435 | alternatively | 548 |
| 436 | proprioceptively | 1 |
| 437 | pre-eruptively | 2 |
| 438 | correspondingly | 241 |
| 439 | astoundingly | 1 |
| 440 | accordingly | 1,478 |
| 441 | encouragingly | 15 |
| 442 | enduringly | 3 |
| 443 | reassuringly | 11 |
| 444 | promisingly | 2 |
| 445 | surprisingly | 892 |
| 446 | unsurprisingly | 10 |
| 447 | disconcertingly | 2 |
| 448 | similarily | 3 |
| 449 | complementarily | 13 |
| 450 | analogically | 2 |
| 451 | monophasically | 1 |
| 452 | mechanistically | 184 |
| 453 | paradoxically | 258 |
| 454 | antisocially | 1 |
| 455 | biexponentially | 1 |
| 456 | similarly | 5,480 |
| 457 | analogously | 16 |
| 458 | paco2significantly | 1 |
| 459 | ignorantly | 1 |
| 460 | correspondently | 2 |
| 461 | congruently | 7 |
| 462 | firstly | 527 |
| 463 | relativly | 1 |
| 464 | pneumo-otoscopy | 2 |
| 465 | aflagellary | 1 |
| 466 | cochleotoxicity | 2 |
| 467 | thermo-alkali-stability | 2 |
| 468 | radiationsensibility | 1 |
| 469 | maxclarity™ | 1 |
| 470 | 2.81‰ | 1 |
| 471 | 107.4° | 1 |
| 472 | 9.38° | 1 |
| 473 | δt° | 1 |
| 474 | 9.6º | 1 |